Baseline neurocognitive deficits in the CATIE schizophrenia trial.
Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA.
Keefe RS, et al. Among authors: stroup ts.
Neuropsychopharmacology. 2006 Sep;31(9):2033-46. doi: 10.1038/sj.npp.1301072. Epub 2006 Apr 19.
Neuropsychopharmacology. 2006.
PMID: 16641947
Clinical Trial.